$RLFTF $NRXP DD (related) by rk on Yh0 - On how l
Post# of 653
-Redemsivir with Baricitinib request filed 10/07/20, approved 11/19/20 (44 days or 6 weeks, 2 days)
-Casirivimab with Imdevimab request filed 10/09/20, approved 11/21/20 (44 days or 6 weeks, 2 days)
-Bamlanivimab request filed 10/08/20, approved 11/09/20. (33 days or 4 weeks, 5 days)
-Bamlanivimab and Etesevimab -
Blaze Trial ended 1/26/2021 EUA approved 02/09/2021. (15 days from trials end)
-Sotrovimab filed 3/10/ 2021 or later in March, approved 5/26/2021 (78 days or 11 weeks + 1 day)
So we have 44 days twice, 33 days 78 days (or less), 15 days from end of a trial.